Instellingen beheren
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Tijs Merckaert
Profile
Projects
Publications & Research Data
Activities
Awards & Distinctions
Patents
4
Results
2024
Towards improved Parsortix® efficiency for circulating tumor cell enrichment in pancreatic cancer
Nele Vandenbussche
Béatrice Lintermans
Tijs Merckaert
Charlotte Fieuws
Kris Gevaert
Kathleen Claes
C3
Conference
2024
2021
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells
Tijs Merckaert
Olivier Zwaenepoel
Kris Gevaert
Jan Gettemans
A1
Journal Article
in
BIOMEDICINE & PHARMACOTHERAPY
2021
Unravelling AKT2 signalling in cancer through nanobody technology
Tijs Merckaert
Jan Gettemans
Kris Gevaert
Dissertation
2021
2020
Development and characterization of protein kinase B/AKT isoform-specific nanobodies
Tijs Merckaert
Olivier Zwaenepoel
Kris Gevaert
Jan Gettemans
A1
Journal Article
in
PLOS ONE
2020